FDA Inspection
Astellas Ireland Co., Ltd.Astellas Ireland Co., Ltd. – FDA Inspection, Jan 17, 2020
Record Details
This FDA Inspection record concerns Astellas Ireland Co., Ltd., with an inspection on January 17, 2020, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Astellas Ireland Co., Ltd.
- Inspection Date
- January 17, 2020
- Product Type
- Drugs
View Company Profile
ID · 1e80cd1a-7004-489e-90b0-7f7f8e64a4b0
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1127818
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Astellas Ireland Co., Ltd.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| June 17, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 12, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 19, 2013 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Astellas Ireland Co., Ltd.
- FDA Inspection 1271041 - 2022-06-17
- FDA Inspection 962296 - 2016-02-12
- FDA Inspection 853359 - 2013-09-19
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.